Leaky Gut: Real Mechanism, Broken Test, Fake Syndrome
Summary
Intestinal permeability is a real, measurable property of the gut barrier whose pathological increase is genuinely documented in coeliac disease and IBD (Tier 1 for the phenomenon) — but "leaky gut syndrome," the marketed claim that a porous bowel is the hidden root cause of fatigue, autoimmunity, migraine, and autism and is fixed by glutamine/collagen/"gut repair" blends and open-ended elimination diets, is medically unrecognised, sold on a broken biomarker (the commercial zonulin test), and unsupported by evidence (Tier 3/4 for the syndrome). The honest middle is small: support the real diag
Why Moderate
Tier 2 (Moderate) for the entry overall because the honest, defensible content is a small well-supported middle: the barrier phenomenon and its modifiable insults are solid, but the marketed syndrome — which is what most users are actually asking about — is not.
• The phenomenon is Tier 1 in defined conditions (coeliac, IBD): tight-junction biology, raised permeability, and the NSAID/alcohol/exercise insults are well established.
• The broken-biomarker critique is Tier 1: controlled assay work (Scheffler 2018; Massier/Ajamian 2018) directly demonstrates the commercial zonulin ELISA doesn't measure what it claims.
• The syndrome causation is Tier 3/4: the systemic-disease links are hypothesis with unestablished or reversed causation; medical bodies reject the diagnosis.
• The supplement claims are Tier 3: glutamine is context-confined; collagen/bone-broth/prebiotic-for-permeability claims lack adequate trials.
NOT Tier 1 overall because the dominant public claim (the syndrome) is unsupported. NOT Tier 3 overall because the underlying barrier biology and the biomarker critique are genuinely strong — this isn't merely emerging, it's a real mechanism wrapped in a fake syndrome.
Practical takeaway
The honest framing: support the real condition if you have one, cut the documented insults, eat for the barrier the boring way, and don't buy the test or the blends.
• Get assessed if you have GI red flags. Persistent diarrhoea, blood in stool, unexplained weight loss, or severe pain → see a clinician for coeliac/IBD workup. Those are the real, treatable conditions where permeability genuinely matters. Don't self-diagnose "leaky gut" over them.
• Cut the insults you control. Chronic or unnecessary NSAID use and regular heavy alcohol both measurably raise permeability — higher-yield than any supplement.
• Eat for the barrier the supported way. Adequate fibre, varied whole foods, enough protein — feeding the microbiome and its short-chain-fatty-acid production is the defensible move (see dietary_fiber_diversity_and_microbiome_health). No proprietary blend beats this.
• Don't buy a consumer "zonulin" or "leaky gut" test. The common commercial assay isn't validated against actual permeability; a result from it shouldn't drive any decision.
• Skip self-directed "gut repair." Glutamine, collagen, and bone-broth protocols for vague symptoms are unproven outside specific clinical settings. If elimination is genuinely warranted, run it time-limited and supervised, with reintroduction — not as a permanent restriction (see elimination_protocols).
Evidence detail
Why This Entry Exists
"Leaky gut" is one of the most successful pieces of wellness vocabulary of the last decade — a phrase that sounds mechanistic, feels intuitive (a bowel that leaks), and conveniently explains any symptom a person can't otherwise account for. Around it has grown an entire commercial ecosystem: consumer "zonulin" blood and stool tests, glutamine and bone-broth "gut-healing" protocols, and permanent elimination diets, sold largely by supplement vendors and functional-medicine practitioners who also bill for the workup.
The problem is that two completely different things share the name. Intestinal permeability is real physiology with Tier 1 support in defined diseases. "Leaky gut syndrome" is a marketing construct that takes that real mechanism, inflates it into the cause of everything, and attaches a product funnel. Collapsing the two is how a legitimate barrier-biology fact gets laundered into a supplement sale — and how the honest skeptic, recoiling from the hype, sometimes throws out the real mechanism with it.
So this entry does the Realised double move: keep the real phenomenon, name the broken test, and refuse the syndrome-as-cause-of-everything narrative — while also refusing the opposite overcorrection that dismisses intestinal permeability as pure nonsense.
What bad advice this protects against, in both directions:
• "Your symptoms are leaky gut — heal it with this supplement stack" → you buy an unvalidated test and unproven blends, and miss the real, treatable condition (coeliac, IBD) where permeability actually matters.
• "Leaky gut is total pseudoscience, the gut barrier is irrelevant" → the opposite overcorrection; intestinal permeability is a genuine, central feature of coeliac and IBD, and the broken-biomarker critique came from mainstream researchers, not just skeptics.
• "Run an open-ended elimination diet to fix it" → restriction without a confirmed trigger risks nutrient gaps and disordered-eating patterns (see elimination_protocols).
It does not own the microbiome (see dietary_fiber_diversity_and_microbiome_health), SIBO (small_intestinal_bacterial_overgrowth), or IBS (ibs_diagnostic_lifestyle). It owns the leaky-gut decision: is the barrier real, is the test valid, is the syndrome a thing, and what actually helps.
Evidence
1. The barrier and its biology are real (Tier 1, in defined conditions). The gut lining is sealed by tight junctions — protein complexes (occludin, ZO-1, claudins) that control paracellular permeability, regulated in part by the protein zonulin. Raised permeability is a genuine, central feature of coeliac disease (zonulin elevated in the acute phase) and is associated with IBD (downregulated and redistributed ZO-1 and occludin). Fasano's Physiological Reviews (2011) lays out the tight-junction/zonulin biology — note this is the proponent source making the strong-form case, but the underlying barrier physiology is not in dispute.
2. Permeability is raised by identifiable, modifiable insults (Tier 1). Chronic NSAID use, acute alcohol, and intense endurance exercise under heat (splanchnic ischaemia) all measurably increase permeability on validated dual-sugar / sucrose permeability tests. This is the actionable real signal: a small set of insults you can actually reduce — not a mysterious syndrome.
3. Where permeability is downstream of disease, treat the disease (Tier 1). In coeliac and IBD, the barrier improves when the underlying inflammation is controlled — zonulin and measured permeability fall as IBD is brought under control. The lever is the diagnosis and its treatment, not a bolt-on "gut-healing" protocol.
4. The headline biomarker is broken (Tier 1 for the critique). The widely sold commercial zonulin ELISA does not actually detect pre-haptoglobin-2 (the proposed zonulin) — Scheffler et al. (Frontiers in Endocrinology, 2018) showed it cross-reacts with properdin and other unidentified proteins. Massier and Ajamian ("Blurring the picture in leaky gut research," PLOS One lineage, 2018) found the assay measures unknown proteins and correlates poorly with actual functional permeability (lactulose-mannitol R ≈ 0.03–0.17, non-significant). Consumer zonulin/"leaky gut" blood and stool tests are not validated, and much existing "zonulin = leaky gut" literature must be read with great caution.
5. The "cause of everything" disease links fail (Tier 3/4). Attributing chronic fatigue, rheumatoid arthritis, lupus, MS, migraine, and autism to leaky gut is hypothesis, not evidence — the direction of causation is usually unestablished or reversed (permeability is frequently a marker or consequence of inflammation, not its origin). Medical bodies are explicit: NHS, Mayo Clinic, and the Canadian Society of Intestinal Research (badgut.org) state "leaky gut syndrome" is not a recognised diagnosis and there is little evidence a porous bowel causes the systemic diseases attributed to it.
6. The "gut-healing" supplements are largely unproven (Tier 3). Glutamine has signal only in specific clinical contexts (critical illness, burns, possibly as a low-FODMAP adjunct in IBS) — not as a cure for vague-symptom "leaky gut" in otherwise-healthy people. Collagen, bone broth, and proprietary "gut repair" blends lack adequate trials. A 2024 systematic review (Glycoconjugate Journal) found only limited support for a direct prebiotic→permeability link in humans.
Mechanism
What the barrier actually does. The single-cell epithelial lining is the body's largest interface with the outside world. Tight junctions between cells regulate what passes between them (the paracellular route); zonulin reversibly loosens these junctions. This is normal, regulated physiology — the gut is meant to be selectively permeable. "Leaky" only becomes pathological when junctions are persistently disrupted, as in coeliac (gliadin triggers zonulin release) or active IBD.
Why permeability is usually downstream, not upstream. In the conditions where raised permeability is best documented, it tracks with inflammation rather than preceding it. Inflammation disrupts the junctions; the disrupted junctions can then let more antigen through, which can feed the inflammation — a loop, but one whose entry point is the disease, not a free-floating "leak." This is why treating the diagnosis improves the barrier, and why a "seal the leak" supplement aimed at the barrier in isolation has little to grab onto in a healthy person.
Why the zonulin test fails mechanistically. The commercial assay was assumed to bind pre-haptoglobin-2. It doesn't — it binds properdin and other proteins, so the number it returns isn't even measuring the molecule the whole model is built on, and it barely correlates with the lactulose-mannitol functional test that does measure permeability directly. A biomarker that doesn't track the thing it claims to measure can't drive a decision.
Why the modifiable insults are the real lever. NSAIDs inhibit prostaglandin-mediated mucosal protection; alcohol is directly toxic to the epithelium; heat-stress endurance exercise diverts blood from the gut (splanchnic ischaemia). Each measurably raises permeability — and each is something a person can actually reduce. That, plus feeding the barrier with fibre and whole foods, is the entire defensible toolkit.
Risks And Contraindications
• Missing a real diagnosis. The biggest harm of the "leaky gut" frame is that it sits in front of coeliac, IBD, SIBO, and IBS — a self-diagnosis that delays the workup that would actually help. GI red flags are a clinician question, not a supplement question.
• Unvalidated testing driving decisions. Acting on a consumer zonulin/"leaky gut" result means making elimination or supplement decisions on a number that doesn't measure permeability. The test result is the hazard.
• Open-ended elimination diets are not benign. Cutting foods for vague symptoms without a confirmed trigger risks nutrient deficiency, food anxiety, and disordered-eating patterns, and misattributes normal digestion. This is the wellness-side overcorrection — symmetric to the supplement hype — and it should only run supervised.
• Glutamine is not a free pass. Its evidence is confined to specific clinical contexts; megadosing it as a general "gut sealer" is unproven and not risk-free in some populations.
• The "natural and gentle" framing is itself the trap. Bone broth and collagen feel harmless, so people defer real assessment to chase them. The cost is the delay, not the broth.
Controversy
Nature: commercial / functional-medicine marketing, with overstatement at both poles.
Position A — "Leaky gut is the hidden root cause of your symptoms; heal it with this protocol." The wellness/functional-medicine take.
• Best evidence: intestinal permeability is real and genuinely matters in coeliac and IBD.
• Where it's wrong: the systemic-disease links (CFS, RA, lupus, MS, migraine, autism) are hypothesis with causation usually unestablished or reversed; the commercial zonulin test is broken; and the "gut repair" blends are unproven. NHS, Mayo, and badgut.org all reject the syndrome as a diagnosis.
Position B — "Leaky gut is pure pseudoscience; the gut barrier is irrelevant." The reflexive-skeptic take.
• Best evidence: the syndrome construct and the consumer products deserve dismissal.
• Where it's wrong: intestinal permeability is a real, Tier-1 feature of coeliac and IBD, and the broken-biomarker critique came from mainstream researchers (Scheffler; Massier/Ajamian), not contrarians. Dismissing the mechanism along with the marketing is its own error.
The funding/bias dimension — cui bono, both ways. The supplement and functional-medicine industry profits directly: unvalidated zonulin tests, glutamine/collagen/"gut-repair" blends, and open-ended elimination protocols are all billable, and most pro-"leaky gut" web content traces to vendors or practitioners selling the workup. On the other side, a blanket "it's all nonsense" dismissal would wrongly discount a real mechanism and a validly broken biomarker that mainstream science flagged — discarding a legitimate finding because it shares a name with a scam.
Realised Position: Intestinal permeability is real and matters in coeliac and IBD; the commercial zonulin test is broken; "leaky gut syndrome" as the cause of everything is unsupported and its product funnel should be refused. Support the real condition, cut the documented insults (NSAIDs, alcohol), eat fibre and whole foods, and stop there. Not "miracle cure," not "pure pseudoscience."
Cross-Pillar Connections
• Diet (small_intestinal_bacterial_overgrowth): a real, diagnosable gut condition that "leaky gut" self-diagnosis often sits in front of — the workup that actually matters.
• Diet (ibs_diagnostic_lifestyle): another genuine condition the leaky-gut frame obscures; where glutamine-as-low-FODMAP-adjunct has its narrow, legitimate context.
• Diet (dietary_fiber_diversity_and_microbiome_health): the supported, recovery-posture barrier move — fibre and microbiome feeding — that no proprietary blend beats.
• Diet (elimination_protocols): how to run elimination correctly (time-limited, supervised, with reintroduction) versus the open-ended restriction the leaky-gut frame encourages.
• Diet (detox_cleanse_claims): the sibling "your body is full of hidden gunk, buy this to flush it" wellness pattern — same product funnel, same cui-bono structure.
What would change our mind
• We'd upgrade the syndrome toward real status if prospective human studies showed raised permeability preceding and predicting the onset of the attributed systemic diseases (not merely co-occurring), establishing causal direction rather than the marker-of-inflammation pattern we currently see.
• We'd rehabilitate the zonulin test if a validated assay that genuinely measures pre-haptoglobin-2 and correlates with functional permeability (lactulose-mannitol) replaced the current cross-reacting ELISA.
• We'd support a "gut-healing" supplement if adequately powered RCTs showed glutamine/collagen/prebiotics improving functional permeability and symptoms in otherwise-healthy people with vague complaints — current evidence is limited and context-confined.
• What would NOT move us: the reality of tight-junction biology and raised permeability in coeliac/IBD (settled), the NSAID/alcohol/exercise insult data (settled), and the fact that the current commercial zonulin ELISA cross-reacts with properdin (demonstrated). These stand regardless.
Industry bias note
This is a two-sided-incentive topic, which is exactly why independent assay science and medical-body consensus are the anchors.
• The supplement/functional-medicine end: the entire "leaky gut" funnel is commercial — unvalidated zonulin tests, glutamine/collagen/"gut-repair" blends, and open-ended elimination protocols are all things vendors and practitioners sell. The "natural = gentle" halo is convenient because it defers the real workup. Most pro-"leaky gut" web content is from sellers (note the supplement-seller bias running through this literature).
• The opposite overcorrection: a flat "it's all pseudoscience" dismissal would wrongly bin a real mechanism (coeliac/IBD permeability) and a validly broken biomarker that mainstream researchers — not skeptics — exposed. That overcorrection is cheaper to make than to defend.
• The clean signal: controlled assay studies (Scheffler 2018; Massier/Ajamian 2018), medical-body positions (NHS, Mayo, Canadian Society of Intestinal Research), and an independent 2024 systematic review on prebiotics-and-permeability — none of them selling a test or a blend. Realised weights those over both the product funnel and the reflexive dismissal.
Sources (7)
- Scheffler L, et al. (2018), Frontiers in Endocrinology (PMC5807381). (Independent/academic assay study.) — the widely used commercial zonulin ELISA does NOT detect pre-haptoglobin-2; it recognises properdin instead.↗
- Massier L / Ajamian M, et al. (2018), "Blurring the picture in leaky gut research" (PMC8355880). (Independent/academic.) — zonulin ELISA measures unknown proteins; weak, non-significant correlation with functional permeability (R = 0.03–0.17); existing literature must be read with caution.↗
- Fasano A. (2011), Physiological Reviews. (Proponent source — the strong-form case.) — zonulin biology, tight-junction regulation, and the proposed role in coeliac and autoimmune barrier disruption.↗
- Canadian Society of Intestinal Research, "Debunking the Myth of Leaky Gut Syndrome" (badgut.org). (Medical-body position.) — the syndrome construct is unsupported; little evidence a porous bowel causes the attributed systemic diseases. (Convergent with NHS and Mayo Clinic statements.)↗
- Systematic review (2024), Glycoconjugate Journal. (Independent/academic.) — only limited support for a direct prebiotic→intestinal-permeability connection in humans.↗
- Healthline, "Is Leaky Gut Real?" (Independent balanced summary.) — glutamine evidence is limited to specific clinical settings, not a generalised cure.↗
- Funding notation: anchored on independent assay studies (Scheffler; Massier/Ajamian), convergent medical-body positions (NHS, Mayo, Canadian Society of Intestinal Research), and an independent 2024 systematic review — none selling a test or a supplement. Fasano (2011) is cited as the proponent source to represent the strong-form case fairly; the broken-biomarker critique came from mainstream researchers, not from the wellness-skeptic fringe.*↗